Versant Venture Capital III, L.P., Ten Percent Owner at Ocular Therapeutix, holds 2.22M shares in Ocular Therapeutix (Ticker: OCUL), holds 2.25K shares in Flexion Therapeutics (Ticker: FLXN), holds 1.97M shares in Immune Design (Ticker: IMDZ). Most recently, Versant Venture Capital III, L.P. Sold ― shares of Ocular Therapeutix on Jun 15, 2015 for an estimated value of 7.04M.